OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
15.63
-0.52 (-3.22%)
Nov 13, 2025, 1:49 PM EST - Market open
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $291.35 million as of November 13, 2025. Its market cap has increased by 191.35% in one year.
Market Cap
291.35M
Enterprise Value
303.89M
1-Year Change
191.35%
Ranking
Category
Stock Price
$15.63
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $291.35M, an increase of 751.91%. That is a compound annual growth rate of 33.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 296.20M | 230.95% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
| Jun 22, 2018 | 34.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 923.44B |
| Johnson & Johnson | 470.63B |
| AbbVie | 420.37B |
| UnitedHealth Group | 305.61B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 232.69B |
| Abbott Laboratories | 224.05B |